Sesquiterpene lactones with dual inhibitory activity against the trypanosoma brucei pteridine reductase 1 and dihydrofolate reductase

The parasite Trypanosoma brucei (T. brucei) is responsible for human African trypanosomi-asis (HAT) and the cattle disease “Nagana” which to this day cause severe medical and socio-eco-nomic issues for the affected areas in Africa. So far, most of the available treatment options are ac-companied by harmful side effects and are constantly challenged by newly emerging drug re-sistances. Since trypanosomatids are auxotrophic for folate, their pteridine metabolism provides a promising target for an innovative chemotherapeutic treatment. They are equipped with a unique corresponding enzyme system consisting of the bifunctional dihydrofolate reductase-thymidylate synthase (TbDHFR-TS) and the pteridine reductase 1 (TbPTR1). Previously, gene knockout experi-ments with PTR1 null mutants have underlined the importance of these enzymes for parasite sur-vival. In a search for new chemical entities with a dual inhibitory activity against the TbPTR1 and TbDHFR, a multi-step in silico procedure was employed to pre-select promising candidates against the targeted enzymes from a natural product database. Among others, the sesquiterpene lactones (STLs) cynaropicrin and cnicin were identified as in silico hits. Consequently, an in-house database of 118 STLs was submitted to an in silico screening yielding 29 further virtual hits. Ten STLs were subsequently tested against the target enzymes in vitro in a spectrophotometric inhibition assay. Five compounds displayed an inhibition over 50% against TbPTR1 as well as three compounds against TbDHFR. Cynaropicrin turned out to be the most interesting hit since it inhibited both TbPTR1 and TbDHFR, reaching IC50 values of 12.4 µM and 7.1 µM, respectively.